Skip to main content
Clinical Trials/NCT05682677
NCT05682677
Recruiting
Not Applicable

Combined Neuromodulation and Cognitive Training for Post-mTBI Depression

University of California, San Diego2 sites in 1 country72 target enrollmentSeptember 19, 2023

Overview

Phase
Not Applicable
Intervention
iTBS
Conditions
Depression
Sponsor
University of California, San Diego
Enrollment
72
Locations
2
Primary Endpoint
Hamilton Rating Scale for Depression
Status
Recruiting
Last Updated
yesterday

Overview

Brief Summary

The primary goal of this clinical trial is to evaluate whether Personalized Augmented Cognitive Training (PACT) plus intermittent theta burst stimulation (iTBS) is effective for treating depression in Service Members, Veterans, and civilians who have sustained a mild TBI. Participants will receive PACT plus 20 sessions of iTBS or sham iTBS over 4 weeks. Assessments will occur at baseline, 2 weeks, 4 weeks, and 8 weeks. Researchers will compare the PACT+iTBS group to the PACT+sham iTBS group to see if PACT+iTBS is associated with more depression improvement.

Registry
clinicaltrials.gov
Start Date
September 19, 2023
End Date
June 30, 2027
Last Updated
yesterday
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Elizabeth Twamley

Professor of Psychiatry

University of California, San Diego

Eligibility Criteria

Inclusion Criteria

  • Male or female
  • All racial and ethnic groups
  • Ages 18 to 65
  • Military service members receiving treatment at NMCSD or civilians receiving treatment at UCSD Health
  • History of mild TBI (as defined by the DoD/VA criteria used in conjunction with the OSU TBI-ID method) over 3 months prior to study entry
  • Meets criteria for current Major Depressive Episode within the context of Major Depressive Disorder, per MINI
  • Score of 18 or higher on the HAMD-17, indicating moderate to severe depressive symptoms
  • Stable on psychiatric medications for 6 weeks, with no changes to psychiatric medications expected during the study period
  • No contraindications to TMS (passes the TMS Adult Safety Screening questionnaire)
  • No contraindications to MRI (passes MRI safety screening questionnaire)

Exclusion Criteria

  • History of moderate, severe, or penetrating TBI
  • History of other neurological condition unrelated to TBI, including but not limited to: conditions associated with increased intracranial pressure; space occupying brain lesions; cerebral aneurysm; stroke; transient ischemic attack within past two years; Parkinson's disease; Huntington's disease; dementia; multiple sclerosis; history of brain surgery; epilepsy; seizure except those therapeutically induced by electroconvulsive therapy (ECT) or a febrile seizure of infancy
  • Implanted medical devices including cardiac pacemaker, medication pump, aneurysm clip, shunt, stimulator, cochlear implant, electrodes, or any other metal object within or near the head (excluding the mouth) that cannot be safely removed
  • Active manic or psychotic illness per MINI
  • Current substance use disorder per MINI
  • Current active suicidal or homicidal ideation
  • Pregnant or intending to become pregnant within the study period; breastfeeding
  • Other sensory conditions or illnesses precluding participation in assessments or treatment
  • Current dose of lorazepam 2 mg or greater daily (or benzodiazepine equivalent) or any anticonvulsant due to the potential to limit iTBS efficacy
  • Taking medication that lowers seizure threshold

Arms & Interventions

PACT+iTBS

Personalized, Augmented Cognitive Training (PACT; 6 sessions over 4 weeks) + intermittent theta burst stimulation (iTBS; 20 sessions over 4 weeks)

Intervention: iTBS

PACT+iTBS

Personalized, Augmented Cognitive Training (PACT; 6 sessions over 4 weeks) + intermittent theta burst stimulation (iTBS; 20 sessions over 4 weeks)

Intervention: Personalized, Augmented Cognitive Training (PACT)

PACT+sham iTBS

Personalized, Augmented Cognitive Training (PACT; 6 sessions over 4 weeks) + sham intermittent theta burst stimulation (sham iTBS; 20 sessions over 4 weeks)

Intervention: sham iTBS

PACT+sham iTBS

Personalized, Augmented Cognitive Training (PACT; 6 sessions over 4 weeks) + sham intermittent theta burst stimulation (sham iTBS; 20 sessions over 4 weeks)

Intervention: Personalized, Augmented Cognitive Training (PACT)

Outcomes

Primary Outcomes

Hamilton Rating Scale for Depression

Time Frame: change over 8 weeks

Secondary Outcomes

  • WAIS-IV Processing Speed(change over 8 weeks)
  • PROMIS Cognitive Function Abilities Short Form(change over 8 weeks)
  • WMS-IV Digit Span(change over 8 weeks)
  • Hopkins Verbal Learning Test - Revised(change over 8 weeks)
  • Patient Health Questionnaire-9(change over 8 weeks)
  • Neurobehavioral Symptom Inventory(change over 8 weeks)
  • PTSD Checklist for DSM-5(change over 8 weeks)
  • Headache Impact Test(change over 8 weeks)
  • Pittsburgh Sleep Quality Index(change over 8 weeks)
  • WHO Disability Assessment Schedule(change over 8 weeks)
  • Glasgow Outcome Scale - Extended(change over 8 weeks)
  • Traumatic Brain Injury Quality of Life(change over 8 weeks)
  • Patient Global Impression of Change(rating at 8 weeks)
  • D-KEFS Trail Making Test(change over 8 weeks)
  • D-KEFS Color Word Interference Test(change over 8 weeks)
  • UCSD Performance-Based Skills Assessment-Brief(change over 8 weeks)

Study Sites (2)

Loading locations...

Similar Trials